Division of Signaling and Gene Expression, La Jolla Institute for Immunology, La Jolla, CA, USA.
Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
Nat Immunol. 2021 Aug;22(8):983-995. doi: 10.1038/s41590-021-00964-8. Epub 2021 Jul 19.
The transcription factors nuclear factor of activated T cells (NFAT) and activator protein 1 (AP-1; Fos-Jun) cooperate to promote the effector functions of T cells, but NFAT in the absence of AP-1 imposes a negative feedback program of T cell hyporesponsiveness (exhaustion). Here, we show that basic leucine zipper ATF-like transcription factor (BATF) and interferon regulatory factor 4 (IRF4) cooperate to counter T cell exhaustion in mouse tumor models. Overexpression of BATF in CD8 T cells expressing a chimeric antigen receptor (CAR) promoted the survival and expansion of tumor-infiltrating CAR T cells, increased the production of effector cytokines, decreased the expression of inhibitory receptors and the exhaustion-associated transcription factor TOX and supported the generation of long-lived memory T cells that controlled tumor recurrence. These responses were dependent on BATF-IRF interaction, since cells expressing a BATF variant unable to interact with IRF4 did not survive in tumors and did not effectively delay tumor growth. BATF may improve the antitumor responses of CAR T cells by skewing their phenotypes and transcriptional profiles away from exhaustion and towards increased effector function.
转录因子活化 T 细胞核因子(NFAT)和激活蛋白 1(AP-1;Fos-Jun)合作促进 T 细胞的效应功能,但 NFAT 在缺乏 AP-1 的情况下会对 T 细胞产生负反馈抑制作用,导致 T 细胞低反应性(耗竭)。在这里,我们发现碱性亮氨酸拉链 AT 样转录因子(BATF)和干扰素调节因子 4(IRF4)在小鼠肿瘤模型中合作以拮抗 T 细胞耗竭。在表达嵌合抗原受体(CAR)的 CD8 T 细胞中过表达 BATF 可促进肿瘤浸润性 CAR T 细胞的存活和扩增,增加效应细胞因子的产生,降低抑制性受体和耗竭相关转录因子 TOX 的表达,并支持产生控制肿瘤复发的长寿命记忆 T 细胞。这些反应依赖于 BATF-IRF 相互作用,因为表达一种不能与 IRF4 相互作用的 BATF 变体的细胞不能在肿瘤中存活,也不能有效地延迟肿瘤生长。BATF 可能通过改变 CAR T 细胞的表型和转录谱,使其从耗竭状态向增强的效应功能倾斜,从而改善抗肿瘤反应。
Proc Natl Acad Sci U S A. 2019-5-31
Nature. 2012-9-19
Nat Chem Biol. 2025-8-22
Cell Oncol (Dordr). 2025-8-11
Front Immunol. 2025-7-17
Cell Mol Immunol. 2025-7-10
Nature. 2019-12-4
Nat Rev Immunol. 2019-9-30
Proc Natl Acad Sci U S A. 2019-6-21